Ressources du conférencier
Monographies de produits
-
Canagliflozin. Janssen Inc. Invokana Monographie de produit. June 23, 2023
-
Dapagliflozin. AstraZeneca Inc. Forxiga Monographie de produit. October 10, 2023
-
Dulaglutide. Eli Lilly Canada Inc. Trulicity Monographie de produit. August 25, 2022
-
Empagliflozin. Boehringer Ingelheim Canada Ltd. Jardiance Monographie de produit. January 17, 2024
-
Liraglutide. Novo Nordisk Canada Inc. Victoza Monographie de produit. March 21, 2024
-
Semaglutide. Novo Nordisk Canada Inc. Ozempic Monographie de produit. March 15, 2024
Ressources du programme
Lignes directrices de pratique canadiennes et revues narratives d'experts
-
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure
-
2018 Diabetes Canada Guidelines, Chapter 29: “Chronic Kidney Disease in Diabetes.”
-
2020 Diabetes Canada Update: Pharmacologic Glycemic Management of Type 2 Diabetes in Adults
-
2022 Diabetes Canada Clinical Practice Expert Working Group guidance on Remission in Type 2 Diabetes
-
2021 CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
-
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults
-
2020 Obesity Guidelines: Clinical Practice Guideline on Obesity in Adults
-
2022 Obesity Canada: Pharmacotherapy in Obesity Management (version 2)
-
2022 Management of Type 2 Diabetic Kidney Disease in 2022: A Narrative Review for Specialists and Primary Care
Lignes directrices internationales et rapports de consensus
-
2019 HFA-PEFF Diagnostic Algorithm: A Consensus Recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
-
2022 KDIGO Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
-
2022 Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD): Management of Hyperglycemia in Type 2 Diabetes
-
2023 Focused Update of the 2021 European Society of Cardiology (ESC) Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
-
2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes
-
2023 American College of Cardiology (ACC) Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee
Ressources pour les patients
-
“Stay Safe When You Have Diabetes and Are Sick or at Risk of Dehydration” – Diabetes Canada resource
-
“Top 10 Tips to Sit Less and Move More” – Diabetes Canada resource
-
“Decisional Balance: Weighing the Pros and Cons of Changing (or Not Changing) Behaviour” – Diabetes Canada resource
-
Multidisciplinary Expert Consensus Infographic “Patient Education Prior to GLP-1 RA Start”
-
American Diabetes Association Patient Information on Diabetes-Related Chronic Kidney Disease
